Delivery Order SPE2DR25D3303-SPE2DR26F62D8
- Not listed
- The Defense Logistics Agency awarded a $61,744.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of December 24, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TEZSPIRE 210 mg/1.91 mL pen injectors valued at $7,030.77, with completion scheduled for August 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply arrangements with the Defense Logistics Agency. The product will be...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $7,030.77 on September 19, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This firm fixed price, non-set-aside contract is scheduled for completion by October 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a specific pharmaceutical procurement within the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors, with a ceiling value of $2,343.59. This is a firm fixed-price delivery order with no set-aside designation, requiring completion by November 6, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors valued at $4,687.18, with completion targeted for September 29, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,469.78 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. Performance will be executed from the contractor's Conshohocken, Pennsylvania facility, with completion scheduled for December 31, 2025. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,879.12 by the Defense Logistics Agency on October 28, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. The contract is a firm fixed price delivery order with an ultimate completion date of November 19, 2025, and was competitively awarded with no set-aside designation. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $2,469.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This non-set-aside competitive award is scheduled for completion by December 22, 2025, and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply contract vehicle. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors, with a ceiling value of $4,687.18 and an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a routine...
- The Defense Logistics Agency awarded a $2,469.78 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This non-set-aside, competitively awarded contract carries a firm fixed price and is scheduled for completion by December 24, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DR25D3303Indefinite Delivery Contract
- SPE2DR25D3303-SPE2DR26F62D8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This is a firm fixed-price delivery order with a ceiling value of $2,469.78 and an ultimate completion date of December 17, 2025. The contract was competitively awarded with no set-aside designation. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion and running through December 2026, which serves as the company's primary vehicle for supplying pharmaceuticals and medical supplies to military healthcare systems globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a prime contractor under the DLA Troop Support Medical IDC, the company supplies a comprehensive range of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. This award demonstrates the company's continued capability to fulfill federal requirements through open competition and supports military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 11/24/25 |